Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Alimentary Pharmacology & Therapeutics
|
May 19, 2015
Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B
S Koklu, M T Gulsen, Y Tuna, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 30, 2017
Tetanus in adults: results of the multicenter ID-IRI study
S Tosun, A Batirel, A I Oluk, et al.
Clinical and Experimental Dermatology
|
July 8, 2021
Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients
S Sarıkaya Solak, A Kara Polat, S Kilic, et al.
European Review for Medical and Pharmacological Sciences
|
March 17, 2023
COVID-19: booster(s) vs. hospitalization and Intensive Care Unit admission
O Baydar Toprak, T Akpolat, O Uzun, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Alimentary Pharmacology & Therapeutics
|
May 19, 2015
Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B
S Koklu, M T Gulsen, Y Tuna, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 30, 2017
Tetanus in adults: results of the multicenter ID-IRI study
S Tosun, A Batirel, A I Oluk, et al.
Clinical and Experimental Dermatology
|
July 8, 2021
Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients
S Sarıkaya Solak, A Kara Polat, S Kilic, et al.
European Review for Medical and Pharmacological Sciences
|
March 17, 2023
COVID-19: booster(s) vs. hospitalization and Intensive Care Unit admission
O Baydar Toprak, T Akpolat, O Uzun, et al.
Page
of 2